Luskin MR, Murakami MA, Keating J, et al. Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia. <i>Blood.</i> 2025;145(6):577-589.

Publication Details

Journal
Blood
Published
2025-05-08
DOI
https://doi.org/10.1182/blood.2025029277
Citations
2
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
3.54
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Luskin MR, Murakami MA, Keating J, et al. Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia. Blood. 2025;145(6):577-589.

2 citations
Blood
Chronic Myeloid Leukemia Treatments
3.54
article

Luskin MR, Murakami MA, Keating J, et al. Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia. Blood. 2025;145(6):577-589.

article en
2 citations

Abstract

No abstract available for this paper.
BloodVol. 145(19)
Good health and well-being
Openalex Percentile: Top 8%
Chronic Myeloid Leukemia Treatments
3.54
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Luskin MR, Murakami MA, Keating J, et al. Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia. <i>Blood.</i> 2025;145(6):577-589. · Blood (2025) | TGRS Research Map | TGRS